427 - Developing a Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Further Characterize Impact on Neurodevelopmental Outcomes

Zarena M. Dominguez, University of New Mexico School of Medicine, Albuquerque, NM, United States; Suzy Davies, University of New Mexico School of Medicine, Albuquerque, NM, United States; Tyler Hipple, University of New Mexico, Albuquerque, NM, United States; Curtis D. Mowry, University of New Mexico, Albuquerque, NM, United States; Daniel D. Savage, UNM HSC Department of Neurosciences, Albuquerque, NM, United States; Jessie Maxwell, University of New Mexico School of Medicine, Albuquerque, NM, United States